Title: Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
Journal: British journal of pharmacology 20180601
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20120411
Title: LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells.
Journal: The Journal of cell biology 20101004
Title: Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors.
Journal: Molecular cancer therapeutics 20081101
Title: Ross-Macdonald P, et al. Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther. 2008 Nov;7(11):3490-8.
Title: Petrilli A, et al. LIM Domain Kinases as Potential Therapeutic Targets for Neurofibromatosis Type 2.Oncogene. Oncogene. 2014 Jul 3;33(27):3571-82.
Title: Lunardi P, et al. Effects of Hippocampal LIMK Inhibition on Memory Acquisition, Consolidation, Retrieval, Reconsolidation, and Extinction. Mol Neurobiol. 2017 Jan 13.
